Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
13,253
archived clinical trials in
Arthritis

A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Flowood, MS
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Flowood, MS
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Jackson, MS
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Jackson, MS
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Saint Louis, MO
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Lincoln, NE
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Lincoln, NE
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Omaha, NE
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Las Vegas, NV
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Albuquerque, NM
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Albuquerque, NM
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Roslyn, NY
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Roslyn, NY
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Syracuse, NY
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Syracuse, NY
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Charlotte, NC
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Hickory, NC
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Hickory, NC
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Raleigh, NC
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Raleigh, NC
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Cincinnati, OH
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Oklahoma City, OK
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Tulsa, OK
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Tulsa, OK
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Bend, OR
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Bend, OR
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Bethlehem, PA
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Bethlehem, PA
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Limerick, PA
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Limerick, PA
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Philadelphia, PA
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Pottstown, PA
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Pottstown, PA
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Columbia, SC
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Columbia, SC
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Greenville, SC
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Greenville, SC
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Greer, SC
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Greer, SC
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Myrtle Beach, SC
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Myrtle Beach, SC
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
North Charleston, SC
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
North Charleston, SC
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Knoxville, TN
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Knoxville, TN
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Memphis, TN
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Memphis, TN
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Nashville, TN
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Austin, TX
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Dallas, TX
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Lake Jackson, TX
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Lake Jackson, TX
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Lubbock, TX
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Lubbock, TX
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Mesquite, TX
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Mesquite, TX
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Nassau Bay, TX
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Nassau Bay, TX
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
North Richland Hills, TX
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
North Richland Hills, TX
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
San Antonio, TX
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Sugar Land, TX
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Sugar Land, TX
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Spokane, WA
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Spokane, WA
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
mi
from
Buenos Aires,
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
mi
from
Buenos Aires,
Click here to add this to my saved trials
A Study of LY2127399 in Rheumatoid Arthritis
An Exploratory Open-Label Biomarker Study of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis Receiving Synovial Biopsies
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Frederick, MD
A Study of LY2127399 in Rheumatoid Arthritis
An Exploratory Open-Label Biomarker Study of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis Receiving Synovial Biopsies
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Frederick, MD
Click here to add this to my saved trials
A Study of LY2127399 in Rheumatoid Arthritis
An Exploratory Open-Label Biomarker Study of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis Receiving Synovial Biopsies
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Battle Creek, MI
A Study of LY2127399 in Rheumatoid Arthritis
An Exploratory Open-Label Biomarker Study of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis Receiving Synovial Biopsies
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Battle Creek, MI
Click here to add this to my saved trials
A Study of LY2127399 in Rheumatoid Arthritis
An Exploratory Open-Label Biomarker Study of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis Receiving Synovial Biopsies
Status: Enrolling
Updated:  3/24/2018
mi
from
Mayfield, OH
A Study of LY2127399 in Rheumatoid Arthritis
An Exploratory Open-Label Biomarker Study of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis Receiving Synovial Biopsies
Status: Enrolling
Updated: 3/24/2018
mi
from
Mayfield, OH
Click here to add this to my saved trials
A Study of LY2127399 in Rheumatoid Arthritis
An Exploratory Open-Label Biomarker Study of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis Receiving Synovial Biopsies
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Mesquite, TX
A Study of LY2127399 in Rheumatoid Arthritis
An Exploratory Open-Label Biomarker Study of LY2127399 in Patients With Moderate to Severe Rheumatoid Arthritis Receiving Synovial Biopsies
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Mesquite, TX
Click here to add this to my saved trials
Evaluation of Tabalumab Using Auto-Injector or Prefilled Syringe in Participants With Rheumatoid Arthritis (RA)
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Indianapolis, IN
Evaluation of Tabalumab Using Auto-Injector or Prefilled Syringe in Participants With Rheumatoid Arthritis (RA)
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Evaluation of Tabalumab Using Auto-Injector or Prefilled Syringe in Participants With Rheumatoid Arthritis (RA)
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Lansing, MI
Evaluation of Tabalumab Using Auto-Injector or Prefilled Syringe in Participants With Rheumatoid Arthritis (RA)
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Lansing, MI
Click here to add this to my saved trials
Evaluation of Tabalumab Using Auto-Injector or Prefilled Syringe in Participants With Rheumatoid Arthritis (RA)
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Glendale, AZ
Evaluation of Tabalumab Using Auto-Injector or Prefilled Syringe in Participants With Rheumatoid Arthritis (RA)
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Glendale, AZ
Click here to add this to my saved trials
Evaluation of Tabalumab Using Auto-Injector or Prefilled Syringe in Participants With Rheumatoid Arthritis (RA)
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Lewes, DE
Evaluation of Tabalumab Using Auto-Injector or Prefilled Syringe in Participants With Rheumatoid Arthritis (RA)
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Lewes, DE
Click here to add this to my saved trials
Evaluation of Tabalumab Using Auto-Injector or Prefilled Syringe in Participants With Rheumatoid Arthritis (RA)
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Debary, FL
Evaluation of Tabalumab Using Auto-Injector or Prefilled Syringe in Participants With Rheumatoid Arthritis (RA)
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Debary, FL
Click here to add this to my saved trials
Evaluation of Tabalumab Using Auto-Injector or Prefilled Syringe in Participants With Rheumatoid Arthritis (RA)
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Tamarac, FL
Evaluation of Tabalumab Using Auto-Injector or Prefilled Syringe in Participants With Rheumatoid Arthritis (RA)
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Tamarac, FL
Click here to add this to my saved trials
Evaluation of Tabalumab Using Auto-Injector or Prefilled Syringe in Participants With Rheumatoid Arthritis (RA)
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Prairie Village, KA
Evaluation of Tabalumab Using Auto-Injector or Prefilled Syringe in Participants With Rheumatoid Arthritis (RA)
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Prairie Village, KA
Click here to add this to my saved trials